Your browser doesn't support javascript.
loading
Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment.
Kraus, Christoph; Mkrtchian, Anahit; Kadriu, Bashkim; Nugent, Allison C; Zarate, Carlos A; Evans, Jennifer W.
Afiliação
  • Kraus C; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA. christoph.kraus@nih.gov.
  • Mkrtchian A; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria. christoph.kraus@nih.gov.
  • Kadriu B; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Nugent AC; Institute of Cognitive Neuroscience, University College London, London, UK.
  • Zarate CA; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
  • Evans JW; Section on the Neurobiology and Treatment of Mood Disorders, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Neuropsychopharmacology ; 45(6): 982-989, 2020 05.
Article em En | MEDLINE | ID: mdl-31995812
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / Ketamina Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article